Shenzhen Chipscreen Biosciences Co Ltd Sustainability Reports
The company discovers, develops, and commercializes original small molecule innovative drugs. It primarily focuses on unmet clinical needs within oncology, metabolic diseases, and autoimmune disorders.
Sector: Manufacturing
Country: China
Exchange: Shanghai Stock Exchange
FIGI: BBG00NQLNLH4
3 reports from 2023 to 2025